ARCHIVES

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Jordan Gutterman Selected To Head Lasker Awards Program

January 4, 1991

Advisory Groups: Nominations Sought For Director’s Consumer Liaision Group

June 13, 1997

New NCI division For Center, Training, Organ Systems, Construction Seen As Likely Prospect

April 17, 1987

Also in this 8-page issue: The Cancer Letter wins two awards for its “authoritative examination” of NCI.

June 11, 2004

FDA Guidance for Public Comment at Advisory Committee Meetings

December 10, 2010

Broder’s Conundrum: How To Let Congress Know NCI Needs More Money Without Asking For it

March 17, 1989